SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-034721
Filing Date
2020-06-05
Accepted
2020-06-05 17:10:57
Documents
2
Period of Report
2020-06-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2140
2 POA DOCUMENT poa.txt EX-24.3_920337 2926
  Complete submission text file 0001209191-20-034721.txt   6511
Mailing Address C/O RAPTOR PHARMACEUTICAL CORP 9 COMMERCIAL BLVD, SUITE 200 NOVATO CA 94949
Business Address
Smith Julie (Reporting) CIK: 0001557928 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38938 | Film No.: 20947218

Mailing Address 3 PRESTON COURT BEDFORD MA 01730
Business Address 3 PRESTON COURT BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Issuer) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences